Pediatric Movement Disorders

1987 Baron-Cohen, 1994, Can children with Gilles de la Tourette syndrome edit their intentions?, Psychol Med, 24, 29, 10.1017/S0033291700026805 Black, 1998, Serologic survey of adult patients with obsessive-compulsive disorder for neuron-specific and other autoantibodies, Psychiatry Res, 81, 371, 10.1016/S0165-1781(98)00120-6 Blunt, 1994, Kennard C: Steroid-responsive chorea in childhood following cardiac transplantation, Mov Disord, 9, 112, 10.1002/mds.870090123 Bressman, 1997, Secondary dystonia and the DYT1 gene, Neurology, 48, 1571, 10.1212/WNL.48.6.1571 Bressman, 1986, Fahn S: Essential myoclonus, Adv Neurol, 43, 287 Bressman, 1996, Exclusion of the DYT1 locus in familialn torticollis, Ann Neurol, 40, 681, 10.1002/ana.410400421 Brewer, 1994, Treatment of Wilson's disease with ammonium tetrathiomolybdate: Initial therapy in 17 neurologically affected patients, J Lab Clin Med 123, 41, 304 Brunn, 1988, Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder, Am J Psychiatry, 145, 621, 10.1176/ajp.145.5.621 Brunn, 1997, Budman CL: The course and prognosis of Tourette Syndrome, Neurol Clin, 15, 291, 10.1016/S0733-8619(05)70313-3 Caccia, 1989, Propranolol, clonidine, urapidil and trazodone infusion in essential tremor: A double-blind crossover trial, Acta Neurol Scand, 79, 379, 10.1111/j.1600-0404.1989.tb03804.x Campbell, 1979, The shortest paper, Neurology, 29, 1633, 10.1212/WNL.29.12.1633 Cardoso, 1997, Chorea in 50 consecutive patients with rheumatic fever, Mov Disord, 12, 701, 10.1002/mds.870120512 Cockerell, 1996, Clinical and physiological features of epilepsia partialis continua: Cases ascertained in the UK, Brain, 119, 393, 10.1093/brain/119.2.393 Daube, 1966, Peters HA: Hereditary essential myoclonus, Arch Neurol, 15, 587, 10.1001/archneur.1966.00470180027003 Dening, 1985, Psychiatric aspects of Wilson's disease, Br J Psychiatry, 147, 677, 10.1192/bjp.147.6.677 Eldridge, 1983, Baltic myoclonus epilepsy: Hereditary disorder of childhood made worse by phenytoin, Lancet, 2, 838, 10.1016/S0140-6736(83)90749-3 Factor, 1995, Molho ES: Psychogenic movement disorders: Frequency, clinical profile, and characteristics, J Neurol Neurosurg Psychiatry, 59, 406, 10.1136/jnnp.59.4.406 Fahn, 1986, Generalized dystonia: Concept and treatment, Clin Neuropharmacol, 19, S37, 10.1097/00002826-198600092-00005 Fahn, 1984, The tardive dyskinesias, 229 Fahn, 1986, Van Woert MH: Definition and classification of myoclonus, Adv Neurol, 43, 1 Fahn, 1997, The treatment of dystonia, 359 Fahn, 1988, Williams D: Psychogenic dystonia, Adv Neurol, 50, 431 Fenichel, 1996 Finelli, 1995, Kayser-Fleischer ring: Hepatolenticular degenartion (Wilson's disease), Neuro, 45, 1261, 10.1212/WNL.45.7.1261 Ford, 1995, Treatment of psychogenic movement disorders, 475 Frydman, 1985, Assignment of the gene for Wilson's disease to chrmosome 13, Proc Natl Acad Sci USA, 82, 1819, 10.1073/pnas.82.6.1819 Garvey, 1998, PANDAS: The search for environmental triggers of pediatric neuropsychiatric disorders, 413 Genton, 1990, Guerrini R: Antimyoclonic effects of alcohol in progressive myoclonus epilepsy, Neurology, 40, 1412, 10.1212/WNL.40.9.1412 Gibbs, 1979, Walshe JM: A study of the ceruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups, Q J Med, 48, 447 Greene, 1995, Fahn S: Spread of symptoms in idiopathic torsion dystonia, Mov Disord, 10, 143, 10.1002/mds.870100204 Gulcher, 1997, Mapping of a familial essential tremor gene, FET1, to chromosome lql3, Nature Genet, 17, 84, 10.1038/ng0997-84 Gute, 1985, Baxter LR: Neuroleptic malignant syndrome, New Engl J Med, 313, 163, 10.1056/NEJM198507183130306 Hallet, 1991, Classification and treatment of tremor, JAMA, 226, 115 Hallett, 1997, Kiessling LS: Neuroimmunology of tics and other childhood hyperkinesias, Neurol Clin, 15, 333, 10.1016/S0733-8619(05)70316-9 Hardie, 1991, Neuroacanthocytosis: A clinical, haemato-logical, and pathological study of 19 cases, Brain, 114, 13 Higgins, 1997, Nee LE: A gene (ETM) for essential tremor maps to chromosome 2p22-p25, Mov Disord, 12, 859, 10.1002/mds.870120605 Hoffman, 1990, Feinberg TE: Successful treatment of age-related chorea with sodium valproate, J AM Geriatr Soc, 38, 56, 10.1111/j.1532-5415.1990.tb01598.x Hopkins, 1986, Rosing HS: Myoclonus and mitochondrial myopathy, Adv Neurol, 43, 105 Ichinose, 1994, Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydroalse 1 gene, Nat Genet, 8, 236, 10.1038/ng1194-236 Ilivanainen, 1982, Himberg JJ: Valproate and clonazepam in the treatment of severe progressive myoclonus epilepsy, Neurology, 39, 236 Jamieson, 1996, Ear clicks in palatal tremor caused by activity of the levator veli palatini, Neurology, 46, 1168, 10.1212/WNL.46.4.1168 Jankovic, 1998, Tics and Tourette's Syndrome Jankovic, 1997, Beach J: Long-term effects of tetrabenazine in hyperkinetic movement disorders, Neurology, 48, 358, 10.1212/WNL.48.2.358 Jankovic, 1988, Orman J: Tetrabenazine therapy of dystonia, chorea, tics and other dyskinesias, Neurology, 38, 391, 10.1212/WNL.38.3.391 Jankovic, 1987, Rohaidy H: Motor, behavioral, and pharmacologic findings in Tourette's syndrome, Can J Neurol Sci, 14, 541, 10.1017/S0317167100038087 Kiessling, 1993, Culpepper L: Antineuronal antibodies in movement disorders, Pediatrics, 92, 39, 10.1542/peds.92.1.39 Kitada, 1998, Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, 392, 605, 10.1038/33416 Koller, 1992, Classification of essential tremor, Clin Neuropharmacol, 15, 81, 10.1097/00002826-199204000-00001 Koller, 1986, Royse VL: Efficacy of primidone in essential tremor, Neurology, 36, 121, 10.1212/WNL.36.1.121 Krumholz, 1983, Niedermeyer E: Psychogenic seizures: A clinical study with follow-up data, Neurology, 33, 498, 10.1212/WNL.33.4.498 Kurlan, 1997, Treatment of tics, Neurol Clin, 15, 403, 10.1016/S0733-8619(05)70321-2 Lance, 1986, Action myoclonus, Ramsay Hunt syndrome, and other cerebellar myoclonic syndromes, Adv Neurol, 43, 33 Lance, 1963, Adams RD: The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy, Brain, 86, 111, 10.1093/brain/86.1.111 Leopold, 1985, Kagel MC: Dysphagia in Huntington's disease, Arch Neurol, 42, 57, 10.1001/archneur.1985.04060010063017 Lou, 1991, Tremors, 232 Lozano, 1997, Globus pallidus internus pallidotomy for generalized dystonia, Mov Disord, 12, 841, 10.1002/mds.870120606 Macaya, 1993, DC, Disorders of movement in Leigh's syndrome. Neuropediatric, 24, 60 Marsden, 1984, Origins of normal and pathological tremor, 37 Marsden, 1982, The nosology and pathophysiology of myoclonus, 196 Marsden, 1990, Progressive myoclonic ataxia: The Ramsay Hunt Syndrome, Arch Neurol, 47, 1121, 10.1001/archneur.1990.00530100091019 1986, The focal dystonias, Clin Neuropharmacol, 49, 544 Martin, 1986, Gusella JF: Huntington's disease: Pathogenesis and management, N Engl J Med, 315, 1267 Myers, 1988, Clinical and neuropathologic assessment of severity in Huntington's disease, Neurology, 38, 341, 10.1212/WNL.38.3.341 Nussbaum, 1998, Putting the Parkin into Parkinson's, Nature, 392, 544, 10.1038/33271 Nyaard, 1990, The spectrum of clinical manifestations in a large North American family, Neurology, 40, 66, 10.1212/WNL.40.1.66 Nygaard, 1993, Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q, Nature Genetics, 5, 386, 10.1038/ng1293-386 Oertel, 1997, Wilson's disease, Revolution in Neurology, 140, 53 Ozelius, 1997, The early onset torsion dystonia gene (DYT1) encodes an ATP binding protein, Nat Genet, 17, 40, 10.1038/ng0997-40 Pauls, 1986, Leckman JF: The inheitance of Gille de la Tourette's syndrome and associated behavior: Evidence for autosomal dominant transmission, N Engl J Med, 315, 993, 10.1056/NEJM198610163151604 Paulson GW, Reider CR: Movement disorders in childhood. Move Disord 49:661 Polizos, 1973, Neurological consequences of psychotropic drug withdrawal in schizophrenic children, J Autism Child Schizo, 3, 247, 10.1007/BF01538282 Ptacek, 1996, A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q, Am J Hum Genet, 59, 135 Rajput, 1994, DOPA-responsive dystonia pathological and biochemical observations in a case, Ann Neurol, 35, 396, 10.1002/ana.410350405 Rapin, 1986, Myoclonus in neuronal storage and Lafora Diseases, Adv Neurol, 43, 65 Rasmussen, 1978, Further observations on the syndrome of chronic encephalitis and epilepsy, Applied neurophysiology, 41, 1 Remy, 1995, Peduncular rubral tremor and dopaminergic denervation: A PET study, Neurology, 45, 472, 10.1212/WNL.45.3.472 Robertson, 1989, The Gilles de la Tourette Syndrome; the current status, British Journal of Psychiatry, 154, 147, 10.1192/bjp.154.2.147 Robertson, 1992, Eapen V: Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's syndrome, Clin Neuro, 15, 408 Rubio, 1997, Chorea-acanthocytosis: Genetic linkage to chromosome 9q21, Am J Hum Genet, 61, 899, 10.1086/514876 Saint-Hilaire, 1991, Delayed-onset dystonia due to perinatal or early childhood asphyxia, Neurology, 41, 216, 10.1212/WNL.41.2_Part_1.216 Sawle, 1991, Dopa-responsive dystonia: (F-18) dopa positron emission tomography, Ann Neurol, 30, 24, 10.1002/ana.410300106 Scott, 1996, Donovan DT: Botulinum toxin into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome, Mov Disord, 11, 431, 10.1002/mds.870110413 Sechi, 1989, Treatment of cerebellar tremors with carbama-zepine: A controlled trial with long term follow-up, Neurology, 39, 1113, 10.1212/WNL.39.8.1113 Segawa, 1976, Hereditary progressive dystonia with marked diurnal fluctuation, Adv Neurol, 14, 215 Sethi, 1990, Patel BP: Inconsistenbt response to divalproex sodium in hemichorea/hemiballism, Neurology, 40, 1630, 10.1212/WNL.40.10.1630 Shapiro, 1982, Shapiro E: Clinical efficacy of haloperidol, pimozide, penfluridol, and clonidine in the treatment of Tourette syndrome, Adv Neurol, 35, 413 Shibasaki, 1978, Kuroiwa Y: Electroencephalographic studies of myoclonus, Myoclonus-related cortical spikes and high amplitude somatosensory evoked potentials. Brain, 101, 447 Silva, 1993, Friedhoff AJ: Persistent tardive dyskinesia and other neuroleptic-related dyskinesias in Tourette's disorder, J Chil Adolesc Psychopharmacol, 3, 137, 10.1089/cap.1993.3.137 Singer, 1991, Moran TH: Abnormal dopamine uptake sited in postmortem striatum from patients with Tourette's syndrome, Ann Neurol, 30, 558, 10.1002/ana.410300408 Singer, 1991, Walkup JT: Tourette syndrome and other tic disorders: Diagnosis, pathophysiology, and treatment, Medicine, 70, 15, 10.1097/00005792-199101000-00002 Spitz, 1985, Killian JM: Familial tic disorder, parkinsonism, motor neuron disease, and acanthocytosis-A new syndrome, Neurology, 35, 366, 10.1212/WNL.35.3.366 Swedo, 1994, Sydenham's chorea: A model for childhood autoimmune neuropsychiatric disorders, JAMA, 272, 1788, 10.1001/jama.1994.03520220082035 Swedo, 1993, Sydenham's chorea: Physical and psychological symptoms of St, Vitus dance. Pediatrics, 91, 706 Tan, 1997, The characterization and outcome of stereotypical movements in nonautistic children, Mov Disord, 12, 47, 10.1002/mds.870120109 Thomas, 1995, The Wilson's disease gene: Spectrum of mutations and their consequences, Nature Gen, 9, 210, 10.1038/ng0295-210 Tohru, 1998, Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, 392, 605, 10.1038/33416 Trelles, 1984, Castro C: Successful treatment of two cases of intention tremor with clonazepam, Ann Neurol, 16, 621, 10.1002/ana.410160516 Van Heycap ten Ham, 1994, Lafora disease: A form of progressive myoclonus epilepsy, 382 Wills, 1995, A positron emission tomography study of cerebellar activation associated with essential and writing tremor, Arch Neurol, 52, 299, 10.1001/archneur.1995.00540270095025 Witt, 1992, McLeod syndrome: A distinct form of neuroacan-thocytosis, J Neurol, 239, 302, 10.1007/BF00867584 Williams, 1995, Fahn S: Phenomenology and psychopathology related to psychogenic movement disorders, Adv Neurol, 65, 231 Young, 1986, Shahani BT: Asterixis: One type of negative myclonus, Adv Neurol, 43, 137